Biodegradation of fluoroquinolones by a bacterial consortium

Detalhes bibliográficos
Autor(a) principal: Maia, Alexandra S.
Data de Publicação: 2011
Outros Autores: Duque, Anouk F., Ribeiro, Ana R., Tiritan, Maria E., Castro, Paula M. L.
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.14/13245
Resumo: The present concern in pharmaceuticals in the environment is well known and research studies in this area have been regularly reported. Pharmaceuticals reach the environment by several ways but mostly due to their incorrect disposal and the incomplete elimination during the treatment processes in Wastewater Treatment Plants (WWTP). These residues continuously enter aquatic environments and many of them are resistant to degradation, being so called as pseudo-persistent pollutants. In aquatic compartments, pharmaceutical residues reach concentrations in the ng L-1 to µg L-1 range. This work describes the biodegradation of four fluoroquinolones, Ofloxacin (OFL), Norfloxacin (NOR), Ciprofloxacin (CPF) and Moxifloxacin (MOX), by a bacterial consortium constituted by three bacterial species isolated in our labs, namely F11, FP1 and S2, known to degrade different aromoatic fluorinated compounds. The experiments were conducted in batch mode using a mineral medium supplemented with acetate and 10 mg l-1 of each compound or 10 mg l-1 of a mix of the compounds. The bacterial consortium was capable of aerobic biodegradation of OFL, NOR and CPF during successive feedings of the compounds to the medium, as measured by monitoring removal of the compounds by HPLC-FD and fluoride release by potenciometry. Degradation profile of the fluoroquinolones used in this study indicated that intermediate metabolites were accumulated. Two of the initial constituting strains, F11, belonging to the α-proteobacteria group, and S2, belonging to the Actinobacteria group, were recovered from the medium, F11 predominating in cultures fed with moxifloxacin whereas S2 was mostly found in the remaining cultures. Degradation by single bacteria is under evaluation.
id RCAP_bc32e165243790ef7efb6c7934dfdb10
oai_identifier_str oai:repositorio.ucp.pt:10400.14/13245
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Biodegradation of fluoroquinolones by a bacterial consortiumbiodegradationfluoroquinolonespharmaceuticalsThe present concern in pharmaceuticals in the environment is well known and research studies in this area have been regularly reported. Pharmaceuticals reach the environment by several ways but mostly due to their incorrect disposal and the incomplete elimination during the treatment processes in Wastewater Treatment Plants (WWTP). These residues continuously enter aquatic environments and many of them are resistant to degradation, being so called as pseudo-persistent pollutants. In aquatic compartments, pharmaceutical residues reach concentrations in the ng L-1 to µg L-1 range. This work describes the biodegradation of four fluoroquinolones, Ofloxacin (OFL), Norfloxacin (NOR), Ciprofloxacin (CPF) and Moxifloxacin (MOX), by a bacterial consortium constituted by three bacterial species isolated in our labs, namely F11, FP1 and S2, known to degrade different aromoatic fluorinated compounds. The experiments were conducted in batch mode using a mineral medium supplemented with acetate and 10 mg l-1 of each compound or 10 mg l-1 of a mix of the compounds. The bacterial consortium was capable of aerobic biodegradation of OFL, NOR and CPF during successive feedings of the compounds to the medium, as measured by monitoring removal of the compounds by HPLC-FD and fluoride release by potenciometry. Degradation profile of the fluoroquinolones used in this study indicated that intermediate metabolites were accumulated. Two of the initial constituting strains, F11, belonging to the α-proteobacteria group, and S2, belonging to the Actinobacteria group, were recovered from the medium, F11 predominating in cultures fed with moxifloxacin whereas S2 was mostly found in the remaining cultures. Degradation by single bacteria is under evaluation.Veritati - Repositório Institucional da Universidade Católica PortuguesaMaia, Alexandra S.Duque, Anouk F.Ribeiro, Ana R.Tiritan, Maria E.Castro, Paula M. L.2013-11-14T16:45:21Z20112011-01-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.14/13245engMAIA, Alexandra S. - Biodegradation of fluoroquinolones by a bacterial consortium. In IV International Conference on Environment, Industrial and Applied Microbiology (BioMicroWorld 2011), Málaga, Spain, 14th-16th September 2011. – In BioMicroWorld 2011: Book of Abstracts, p.544info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-09-06T12:07:56Zoai:repositorio.ucp.pt:10400.14/13245Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-09-06T12:07:56Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Biodegradation of fluoroquinolones by a bacterial consortium
title Biodegradation of fluoroquinolones by a bacterial consortium
spellingShingle Biodegradation of fluoroquinolones by a bacterial consortium
Maia, Alexandra S.
biodegradation
fluoroquinolones
pharmaceuticals
title_short Biodegradation of fluoroquinolones by a bacterial consortium
title_full Biodegradation of fluoroquinolones by a bacterial consortium
title_fullStr Biodegradation of fluoroquinolones by a bacterial consortium
title_full_unstemmed Biodegradation of fluoroquinolones by a bacterial consortium
title_sort Biodegradation of fluoroquinolones by a bacterial consortium
author Maia, Alexandra S.
author_facet Maia, Alexandra S.
Duque, Anouk F.
Ribeiro, Ana R.
Tiritan, Maria E.
Castro, Paula M. L.
author_role author
author2 Duque, Anouk F.
Ribeiro, Ana R.
Tiritan, Maria E.
Castro, Paula M. L.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Veritati - Repositório Institucional da Universidade Católica Portuguesa
dc.contributor.author.fl_str_mv Maia, Alexandra S.
Duque, Anouk F.
Ribeiro, Ana R.
Tiritan, Maria E.
Castro, Paula M. L.
dc.subject.por.fl_str_mv biodegradation
fluoroquinolones
pharmaceuticals
topic biodegradation
fluoroquinolones
pharmaceuticals
description The present concern in pharmaceuticals in the environment is well known and research studies in this area have been regularly reported. Pharmaceuticals reach the environment by several ways but mostly due to their incorrect disposal and the incomplete elimination during the treatment processes in Wastewater Treatment Plants (WWTP). These residues continuously enter aquatic environments and many of them are resistant to degradation, being so called as pseudo-persistent pollutants. In aquatic compartments, pharmaceutical residues reach concentrations in the ng L-1 to µg L-1 range. This work describes the biodegradation of four fluoroquinolones, Ofloxacin (OFL), Norfloxacin (NOR), Ciprofloxacin (CPF) and Moxifloxacin (MOX), by a bacterial consortium constituted by three bacterial species isolated in our labs, namely F11, FP1 and S2, known to degrade different aromoatic fluorinated compounds. The experiments were conducted in batch mode using a mineral medium supplemented with acetate and 10 mg l-1 of each compound or 10 mg l-1 of a mix of the compounds. The bacterial consortium was capable of aerobic biodegradation of OFL, NOR and CPF during successive feedings of the compounds to the medium, as measured by monitoring removal of the compounds by HPLC-FD and fluoride release by potenciometry. Degradation profile of the fluoroquinolones used in this study indicated that intermediate metabolites were accumulated. Two of the initial constituting strains, F11, belonging to the α-proteobacteria group, and S2, belonging to the Actinobacteria group, were recovered from the medium, F11 predominating in cultures fed with moxifloxacin whereas S2 was mostly found in the remaining cultures. Degradation by single bacteria is under evaluation.
publishDate 2011
dc.date.none.fl_str_mv 2011
2011-01-01T00:00:00Z
2013-11-14T16:45:21Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/13245
url http://hdl.handle.net/10400.14/13245
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv MAIA, Alexandra S. - Biodegradation of fluoroquinolones by a bacterial consortium. In IV International Conference on Environment, Industrial and Applied Microbiology (BioMicroWorld 2011), Málaga, Spain, 14th-16th September 2011. – In BioMicroWorld 2011: Book of Abstracts, p.544
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817546768671309824